Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Volumn 16, Issue 5, 2005, Pages 490-500

  Layton, Deborah ^a   Clarke, Andrea ^a   Wilton, Lynda V ^a   Shakir, Saad A W ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; FEMALE; FLUSHING; GENERAL PRACTICE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; SPINE FRACTURE; STATISTICS; UNITED KINGDOM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DRUG INTERACTIONS; ENGLAND; FAMILY PRACTICE; FEMALE; FLUSHING; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SPINAL FRACTURES;

EID: 22844450743     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-004-1710-6     Document Type: Article

References (0)